Alessio Gerussi

Monza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis.

Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 10, 2026

Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.

Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.

Journal: Global & regional health technology assessment

Published: February 24, 2026

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 11, 2026

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Journal: BMJ open

Published: January 09, 2026

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Journal: BMJ open

Published: January 09, 2026

Kupffer cell autophagy emerges as a central regulator of immune dysregulation in primary biliary cholangitis.

Kupffer cell autophagy emerges as a central regulator of immune dysregulation in primary biliary cholangitis.

Journal: Gut

Published: December 29, 2025

PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management.

PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management.

Journal: Current opinion in gastroenterology

Published: December 23, 2025

Mechanistic Rationale of Seladelpar's Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary Cholangitis.

Mechanistic Rationale of Seladelpar's Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary Cholangitis.

Journal: Pharmacological research

Published: December 18, 2025

Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the Liver.

Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the Liver.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 16, 2025

Definition, diagnosis, and treatment of primary biliary cholangitis-autoimmune hepatitis (PBC-AIH) variant: An international expert Delphi consensus.

Definition, diagnosis, and treatment of primary biliary cholangitis-autoimmune hepatitis (PBC-AIH) variant: An international expert Delphi consensus.

Journal: Hepatology (Baltimore, Md.)

Published: November 19, 2025

Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensus.

Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensus.

Journal: Hepatology (Baltimore, Md.)

Published: November 19, 2025

Machine learning for population-level risk prediction of future cholangiocarcinoma.

Machine learning for population-level risk prediction of future cholangiocarcinoma.

Journal: EBioMedicine

Published: October 29, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026